...
首页> 外文期刊>Oncology reports >A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis
【24h】

A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis

机译:p53 / miR-19 / TP53INP1的正反馈回路调节胰腺癌细胞的增殖和凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic cancer is a common malignancy whose prognosis and treatment of pancreatic cancer is extremely poor, with only 20% of patients reaching two years of survival. Previous findings have shown that the tumor suppressor p53 is involved in the development of various types of cancer, including pancreatic cancer. Additionally, p53 is able to activate TP53INP1 transcription by regulating several phenotypes of cancer cells. Using gain and loss-of-function assays, the aim of the present study was to examine the relationships between miR-19a/b and cancer development as well as potential underlying mechanisms. The results showed that miR-19a/b identified a positive feedback regulation of p53/TP53INP1 axis. Additionally, p53 upregulated the TP53INP1 level in pancreatic cancer cells. However, overexpressed miR-19a/b partially restored the TP53 function in the pancreatic cancer cells while miR-19a/b downregulated TP53INP1 protein by directly targeting 3'UTR of its mRNA at the post-transcriptional level. In addition, the patient tissues identified that the miR-19a/b level in pancreatic cancer tissues was conversely correlated with TP53 and TP53INP1 expression. The results provide evidence for revealing the molecular mechanism involved in the development of pancreatic cancer and may be useful in the identification of new therapeutic targets for pancreatic cancer.
机译:胰腺癌是一种常见的恶性肿瘤,其胰腺癌的预后和治疗非常差,只有20%的患者可以生存两年。先前的发现表明,肿瘤抑制因子p53参与了包括胰腺癌在内的各种类型癌症的发展。另外,p53能够通过调节癌细胞的几种表型来激活TP53INP1转录。使用功能获得和丧失功能测定,本研究的目的是检查miR-19a / b与癌症发展之间的关系以及潜在的潜在机制。结果表明,miR-19a / b鉴定了p53 / TP53INP1轴的正反馈调节。此外,p53上调了胰腺癌细胞中TP53INP1的水平。然而,过表达的miR-19a / b部分恢复了胰腺癌细胞中的TP53功能,而miR-19a / b通过在转录后水平上直接靶向其mRNA的3'UTR下调了TP53INP1蛋白。此外,患者组织确定胰腺癌组织中的miR-19a / b水平与TP53和TP53INP1表达相反。该结果提供了揭示胰腺癌发展中涉及的分子机制的证据,并且可用于鉴定胰腺癌的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号